Zydus Lifesciences announced that the USFDA conducted a surveillance inspection at the group's API Unit 1, located at Ankleshwar in Gujarat. The inspection was conducted from 10 March to 14 March 2025. The inspection concluded with NIL observations.

Powered by Capital Market - Live News